Morris L, Beltran J, Beltran J, Murrough J, Morel C
Neuroscience. 2025; 569:248-266.
PMID: 39914519
PMC: 11885014.
DOI: 10.1016/j.neuroscience.2025.02.008.
Koirala S, Grimsrud G, Mooney M, Larsen B, Feczko E, Elison J
Nat Rev Neurosci. 2024; 25(12):759-775.
PMID: 39448818
DOI: 10.1038/s41583-024-00869-z.
McCabe V, Veliz P, Wilens T, Schepis T, Pasman E, Evans-Polce R
J Adolesc Health. 2024; 75(1):188-191.
PMID: 38483378
PMC: 11405061.
DOI: 10.1016/j.jadohealth.2024.01.024.
Hendry E, McCallister B, Elman D, Freeman R, Borsook D, Elman I
Neurosci Biobehav Rev. 2024; 158:105566.
PMID: 38307304
PMC: 11082879.
DOI: 10.1016/j.neubiorev.2024.105566.
McCabe S, Schepis T, Schulenberg J, Wilens T, Veliz P
Subst Use Addctn J. 2024; 45(2):314-324.
PMID: 38258848
PMC: 11293527.
DOI: 10.1177/29767342231219139.
Reactive Oxygen Species Mediate Transcriptional Responses to Dopamine and Cocaine in Human Cerebral Organoids.
Rudibaugh T, Stuppy S, Keung A
Int J Mol Sci. 2023; 24(22).
PMID: 38003664
PMC: 10671319.
DOI: 10.3390/ijms242216474.
An Integrated Platform for Electrophysiology in Spatial Cognition Experiments.
Brea Guerrero A, Oijala M, Moseley S, Tang T, Fletcher F, Zheng Y
eNeuro. 2023; 10(11).
PMID: 37989581
PMC: 10668213.
DOI: 10.1523/ENEURO.0274-23.2023.
Functional Connectivity of the Nucleus Accumbens across Variants of Callous-Unemotional Traits: A Resting-State fMRI Study in Children and Adolescents.
Dugre J, Potvin S
Res Child Adolesc Psychopathol. 2023; 52(3):353-368.
PMID: 37878131
PMC: 10896801.
DOI: 10.1007/s10802-023-01143-z.
Whole-Body Vibration Prevents Neuronal, Neurochemical, and Behavioral Effects of Morphine Withdrawal in a Rat Model.
Jones G, Small C, Otteson D, Hafen C, Breinholt J, Flora P
Int J Mol Sci. 2023; 24(18).
PMID: 37762450
PMC: 10532581.
DOI: 10.3390/ijms241814147.
Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement.
Illenberger J, Flores-Ramirez F, Pascasio G, Matzeu A, Martin-Fardon R
Neuropharmacology. 2023; 239:109685.
PMID: 37579870
PMC: 10529002.
DOI: 10.1016/j.neuropharm.2023.109685.
An Integrated Platform for in vivo Electrophysiology in Spatial Cognition Experiments.
Guerrero A, Oijala M, Moseley S, Tang T, Fletcher F, Zheng Y
bioRxiv. 2023; .
PMID: 37577676
PMC: 10418273.
DOI: 10.1101/2023.08.02.551691.
Alcohol cue reactivity in the brain: Age-related differences in the role of social processes in addiction in male drinkers.
Kuhns L, Mies G, Kroon E, Willuhn I, Lesscher H, Cousijn J
J Neurosci Res. 2023; 101(10):1521-1537.
PMID: 37401734
PMC: 10538438.
DOI: 10.1002/jnr.25206.
Neural bases of freedom and responsibility.
Gruart A, Delgado-Garcia J
Front Neural Circuits. 2023; 17:1191996.
PMID: 37334060
PMC: 10272542.
DOI: 10.3389/fncir.2023.1191996.
Self-management with alcohol over lifespan: psychological mechanisms, neurobiological underpinnings, and risk assessment.
Muller C, Schumann G, Rehm J, Kornhuber J, Lenz B
Mol Psychiatry. 2023; 28(7):2683-2696.
PMID: 37117460
PMC: 10615763.
DOI: 10.1038/s41380-023-02074-3.
Integrative Roles of Dopamine Pathway and Calcium Channels Reveal a Link between Schizophrenia and Opioid Use Disorder.
Thiagarajan S, Mok S, Ogawa S, Parhar I, Tang P
Int J Mol Sci. 2023; 24(4).
PMID: 36835497
PMC: 9966501.
DOI: 10.3390/ijms24044088.
The effect of vitamin D on morphine preference in rats: Possible biochemical and DRD2-GDNF signaling.
Saeedfar M, Ardjmand A, Alani B, Ghaderi A, Banafshe H, Shahaboddin M
Brain Behav. 2023; 13(2):e2877.
PMID: 36630182
PMC: 9927858.
DOI: 10.1002/brb3.2877.
Dopaminergic circuits underlying associative aversive learning.
Zafiri D, Duvarci S
Front Behav Neurosci. 2022; 16:1041929.
PMID: 36439963
PMC: 9685162.
DOI: 10.3389/fnbeh.2022.1041929.
Alcohol-induced brain deficit in alcohol dependence.
Wang Y, Sun B
Front Neurol. 2022; 13:1036164.
PMID: 36388224
PMC: 9644208.
DOI: 10.3389/fneur.2022.1036164.
The Genetics of Risk Aversion: A Systematic Review.
Molins F, Sahin F, Serrano M
Int J Environ Res Public Health. 2022; 19(21).
PMID: 36361187
PMC: 9657847.
DOI: 10.3390/ijerph192114307.
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.
Soler-Cedeno O, Xi Z
Cells. 2022; 11(20).
PMID: 36291128
PMC: 9600259.
DOI: 10.3390/cells11203262.